We are pleased to announce the latest bibliometric results for Sarcoidosis, Vasculitis and Diffuse Lung Diseases, which confirm a positive trend in the journal’s scientific visibility and citation performance.

According to the latest Journal Citation Reports™, the journal has received a 2025 Journal Impact Factor of 1.8 in the Respiratory System category and is indexed in the Science Citation Index Expanded (SCIE).

The journal also recorded growth across key Scopus-based indicators. Its 2025 CiteScore increased to 2.0, compared with 1.6 in 2024, while SJR rose from 0.376 to 0.500 and SNIP increased from 0.565 to 0.727.

These results reflect the journal’s continued development and its role as a specialized platform for research on sarcoidosis, vasculitis, diffuse lung diseases, and related respiratory conditions.

We sincerely thank the Editors, Editorial Board members, reviewers, authors, and readers for their continued commitment and contribution to the journal’s growth.